In a recent study, some researchers from the University of Chicago have discovered that cannabidiol may aid in blocking coronavirus in human and mice cells. As per scientists, CBD can interact with the interferon (IFN) signaling pathways and endoplasmic reticulum of the user to stop coronavirus replication.
At the start of the process of research on CBD for COVID-19, study author Glenn Randall remembered that his team brainstormed substances with potential properties against coronavirus. Randall stated that cannabidiol was suggested as it has properties that reduce inflammation that the researchers felt might lessen a very aggressive immune response related to the later phases of coronavirus disease pathology.
As for Randall, there were numerous surprising outcomes in the course of the recent study on CBD and COVID-19 disease. The first of those surprises was that cannabidiol directly blocks the capability of coronavirus to replicate itself in animal models and lung cells with COVID. Cannabidiol directly activated the genes that the human body utilizes to tackle viral infections. The other surprise element was that people who were using FDA-approved CBD for epilepsy had considerably less COVID incidence than comparable patients without CBD prescriptions.
Randall talked about his expectations for the next steps of the researchers to The Maroon. As per the opinion of Randall, you cannot know the worth of cannabidiol in preventing or treating coronavirus disease with no carefully made clinical trial. He also stated that University of Chicago researchers are attempting to develop that kind of trial.
Randall emphasized that this study’s outcomes should not subvert the federal guidelines about coronavirus disease prevention. Neither marijuana nor cannabidiol is a federally accepted way of preventing coronavirus disease. Masking and vaccines are proven ways of preventing severe coronavirus disease, and Randall does not recommend replacing those approaches with cannabidiol.
The Maroon talked to Thomas Best, the Manager of Research and Analytics at CHeSS, regarding what he did for the cannabidiol study. He echoed the surprise of Randall about the outcomes of this study.
Best continued to add checks and balances or an increasing number of controls to try and eliminate confusing evidence. Despite that, there was a considerable negative association between getting a COVID-19 positive test result and having a history of cannabidiol.
Best also discussed the nature of this study that relates to more than one branch of knowledge or discipline in science.